Skip to content

Latest International

Latest International News

Primary Menu
  • Architecture
    • Decorating
    • Design
    • Home Improvement
    • Interiors
    • Make it Modern
  • Fashion
    • Clothes
    • New Look
    • Street Fashion
    • Style Hunter
    • Vogue
  • Sports
    • Cricket
    • Football
    • Racing
  • Technology
    • Mobile Phones
    • Gadgets
    • Gaming
  • friskys
  • itsreleased
  • Home
  • Health & Fitness
  • CRO Diaries: Biomarker Quantification For ELISA Assay Development
  • Health & Fitness

CRO Diaries: Biomarker Quantification For ELISA Assay Development

jhonduncen June 7, 2022

Biomarkers are crucial detection tools in the diagnosis and treatment of diseases. Besides, their accurate detection is vital for different stages of drug development. However, what is the drug development process? The ultimate goal of drug development is to identify and test novel compounds and assess their potential to treat diseases and medical conditions.

Biomarkers are present in serum, blood, tissue, and other body fluids. The primary objective of biomarker quantification is to produce a reliable, cost-effective, and robust assay for diagnosing and monitoring disease conditions. Besides, biomarkers are vital for follow-up treatment.

Since the early use of biomarkers in medical sciences, biomarker technologies have seen massive progress in terms of research studies and innovations. Today numerous biomarker detection methods are available, with ELISA being one of the most employed immunoassays. However, immunoassay services face several drawbacks and limitations during ELISA assay development and validation. Additionally, ELISA assay validation needs an appropriate assessment of accuracy, specificity, and sensitivity for a complete immunoassay validation. The current article discusses several aspects of biomarker quantification for ELISA assay development.

Biomarker quantification for ELISA assay development

In a typical ELISA assay development, antibodies are produced in animals against specific biomarkers. ELISA assays depend on antibody-antigen interaction. Specific epitopes of an antigen will attach to the primary antibody immobilized on the assay plate. The other remaining epitopes will bind to the secondary antibody forming a sandwich-like complex. These binding mechanics are detected using an enzyme that changes the conjugated substrate into a colored outcome. The generated color intensity is directly proportional to the bound antigen in the sample. Such simplified protocols have made ELISA the primary choice for detecting and quantifying biomarkers in biological samples.

There are numerous enzyme-substrate pairs used in ELISA assays. These pairs include alkaline phosphatase-PNPP, alkaline phosphatase-NBT, horseradish peroxidase-ABTS, and horseradish peroxidase-TMB. Despite such a variety of enzyme-substrate pairs, the sensitivity and selectivity of ELISA assays depend on the specific and selective binding of primary and secondary antibodies and the concerned antigen.

Moreover, the binding capacity of secondary antibodies is limited due to their conjugation with a large enzyme. These limitations have paved the way for the development of novel approaches using streptavidin-biotin complexes. This complex bridges the secondary antibody and the enzyme. Biotin is comparatively very small and thus does not significantly change the shape of the secondary antibody. Hence, the secondary antibody retains its specificity against the antigen. Today streptavidin-biotin complex is commonly employed in ELISA assays for sensitive and specific detection of biomarkers.

Besides, the specificity of ELISA assays has limitations as they largely depend on the immobilization chemistry of primary antibodies. Some basic immobilization methods include hydrophobic, ionic, and covalent interactions. Covalent linkage has the disadvantage of reduced protein activity, complicated chemistry, and needs toxic reagents. On the other hand, direct immobilization gradually reduces the activity of primary antibodies, which leads to non-specific interactions. Hence, each immobilization method is unique, and researchers must consider the advantages and limitations of these methods during ELISA assay development and validation.

Continue Reading

Previous: Content Marketing: How to Write Compelling Content that Converts Readers into Customers
Next: Best Tips for your decor with couch covers

Related Stories

Sinus Surgery
  • Health & Fitness

5 Compelling Reasons To Go For A Sinus Surgery

jhonduncen July 11, 2025
  • Health & Fitness

Ayurvedic Oil for Pain: Natural Remedies for Effective Pain Relief

jhonduncen May 15, 2025
Cinnamon
  • Health & Fitness

Using Cinnamon to Spice Up Savory Winter Foods

jhonduncen January 16, 2025

Latest Posts

  • The Evolution of 1xCasino Bonuses from 2020 to 2025: What’s Changed?
  • 5 Compelling Reasons To Go For A Sinus Surgery
  • Skin & Hair Care Bundles – The Smart Way to Upgrade Your Routine
  • How Infinity Pools Are Revolutionizing Luxury Resorts and Hotels
  • 5 Tips for Working with an Explosives Consultant on Construction Sites

You may have missed

  • Gaming

The Evolution of 1xCasino Bonuses from 2020 to 2025: What’s Changed?

RcomAdmin July 16, 2025
Sinus Surgery
  • Health & Fitness

5 Compelling Reasons To Go For A Sinus Surgery

jhonduncen July 11, 2025
AD_4nXc6apcNKqLK08thoYwHooP6I3wle7Wvl-xTTYTLznj-YjVi5zPboWt_N9Q5B8s2za4caHvptNZLG13absYYgSZ099FYSNhs3XxRWtu3HezkKUQeWPiBfBfSs33SEYwe64tdI7spXw?key=avoV0b1pPEJIyympKHG3Wg
  • Fashion

Skin & Hair Care Bundles – The Smart Way to Upgrade Your Routine

RcomAdmin July 10, 2025
Infinity Pools
  • Lifestyle

How Infinity Pools Are Revolutionizing Luxury Resorts and Hotels

jhonduncen July 8, 2025
Copyright © All rights reserved. | MoreNews by AF themes.